Notably, we integrated proteome and transcriptome data with in vitro and in vivo assays, and discovered that APOC2 cooperated with CD36 to regulate EMT of GC cells and caused aberrant phosphorylation of PI3K, AKT and mTOR to promote PM progression in GC. Here, APOC2 is linked to gastric cancer.